4-alkoxypyrrolo[2,1-f][1,2,4]triazines and their preparations and uses

JP2025525391A5Pending Publication Date: 2026-06-30BIOSPLICE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
BIOSPLICE THERAPEUTICS INC
Filing Date
2023-06-23
Publication Date
2026-06-30

Smart Images

  • Figure 2023250156000001
    Figure 2023250156000001
  • Figure 2023250156000002
    Figure 2023250156000002
  • Figure 2023250156000003
    Figure 2023250156000003
Patent Text Reader

Abstract

Disclosed are 4-alkoxypyrrolo[2,1-f][1,2,4]triazine compounds for treating various diseases and pathologies. More specifically, the disclosure relates to the use of 4-alkoxypyrrolo[2,1-f][1,2,4]triazine compounds or analogs thereof in the treatment of disorders characterized by overexpression of DYRK1A (e.g., cancer, Down's syndrome, Alzheimer's disease, diabetes, viral infections, and osteoarthritis).
Need to check novelty before this filing date? Find Prior Art